top of page
Search


FDA General Wellness Policy: What Non-Invasive Sensing Products Must Meet to Remain Low Risk
As wearable and software-enabled technologies increasingly estimate physiological parameters such as oxygen saturation, blood pressure, and heart rate variability, regulatory classification has become a critical design consideration. The FDA’s General Wellness: Policy for Low Risk Devices clarifies when products using non-invasive sensing—such as optical sensing—may be considered general wellness products rather than regulated medical devices. For developers conducting a cl
Feb 163 min read
bottom of page

